Pharmacovigilance and Drug Safety Software Market Size, Report and Outlook 2024-2032

IMARC Group, a leading market research company, has recently releases report titled “Pharmacovigilance and Drug Safety Software Market Report by Functionality (Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software), Delivery Mode (On-premises, Cloud-based), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, and Others), and Region 2024-2032.” Offers a comprehensive analysis of the industry, which comprises insights on the market.

How Big is the Pharmacovigilance and Drug Safety Software Market?

The global pharmacovigilance and drug safety software market size reached US$ 202.3 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 341.5 Million by 2032, exhibiting a growth rate (CAGR) of 5.9% during 2024-2032.

Industry Overview of Pharmacovigilance and Drug Safety Software

Pharmacovigilance and drug safety software are applications that help pharmaceutical companies and research centers in the detection, assessment, understanding, and prevention of long and short-term side effects of medicines. They are used to store adverse events (AE), adverse drug reactions (ADR), serious adverse events (SAE), suspected serious adverse drug reactions (SUSAR), and pregnancy reports during clinical trials (CT) or when a pharmaceutical company has a marketing authorization for a medical product. They also enable healthcare professionals to manage and record pharmacovigilance data, which can be used for growing awareness about the harmful aspects of drugs.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/pharmacovigilance-drug-safety-software-market/requestsample

What are the growth prospects and trends in the pharmacovigilance and drug safety software industry?

At present, the increasing demand for pharmacovigilance and drug safety software due to the rising incidences of adverse drug reactions (ADRs) represents one of the primary factors propelling the growth of the market.

Besides this, the growing implementation of government policies about drug safety regulations is offering a favorable market outlook. In addition, the increasing adoption of pharmacovigilance and drug safety software by outsourcing companies involved in contract research and contract manufacturing is contributing to the growth of the market.

Apart from this, the rising utilization of pharmacovigilance and drug safety software for preventing regulatory non-compliance, monetary fines, and false reporting is supporting the growth of the market.

Leading Companies Operating in the Global Pharmacovigilance and Drug Safety Software Industry:

• Ab Cube
• Anju Software Inc.
• ArisGlobal LLC
• Cognizant
• Ennov Solutions Inc.
• Extedo GmbH
• Max Application
• Oracle Corporation
• Sarjen Systems Pvt Ltd
• Sparta Systems Inc. (Honeywell International Inc.)
• Tata Consultancy Services Limited
• United BioSource LLC
• Wipro Limited.

Pharmacovigilance and Drug Safety Software Market Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Functionality:

• Adverse Event Reporting Software
• Drug Safety Audits Software
• Issue Tracking Software
• Fully Integrated Software

Breakup by Delivery Mode:

• On-premises
• Cloud-based

Breakup by End User:

• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Business Process Outsourcing Firms
• Others

Breakup by Region:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163

Article source: https://article-realm.com/article/Business/58414-Pharmacovigilance-and-Drug-Safety-Software-Market-Size-Report-and-Outlook-2024-2032.html